Kingsview Wealth Management LLC Has $4.24 Million Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Kingsview Wealth Management LLC grew its position in iShares Biotechnology ETF (NASDAQ:IBB) by 805.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 32,084 shares of the financial services provider’s stock after purchasing an additional 28,541 shares during the period. Kingsview Wealth Management LLC’s holdings in iShares Biotechnology ETF were worth $4,242,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Huntington National Bank increased its position in iShares Biotechnology ETF by 17.9% in the 3rd quarter. Huntington National Bank now owns 1,054 shares of the financial services provider’s stock worth $153,000 after purchasing an additional 160 shares during the last quarter. National Bank of Canada FI increased its position in iShares Biotechnology ETF by 5.9% in the 3rd quarter. National Bank of Canada FI now owns 4,124 shares of the financial services provider’s stock worth $600,000 after purchasing an additional 229 shares during the last quarter. Avior Wealth Management LLC boosted its stake in shares of iShares Biotechnology ETF by 438.2% during the 3rd quarter. Avior Wealth Management LLC now owns 3,229 shares of the financial services provider’s stock worth $470,000 after acquiring an additional 2,629 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund boosted its stake in shares of iShares Biotechnology ETF by 32.9% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock worth $96,533,000 after acquiring an additional 164,000 shares in the last quarter. Finally, Main Management ETF Advisors LLC boosted its stake in shares of iShares Biotechnology ETF by 2.5% during the 3rd quarter. Main Management ETF Advisors LLC now owns 593,370 shares of the financial services provider’s stock worth $86,395,000 after acquiring an additional 14,535 shares in the last quarter. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Down 2.1 %

IBB opened at $137.67 on Friday. The stock has a 50-day moving average of $136.22 and a 200-day moving average of $141.38. iShares Biotechnology ETF has a 52-week low of $123.60 and a 52-week high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The firm also recently announced a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were paid a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.